DNA Labs India
DNA Labs India is a Hyderabad-headquartered private genetic testing laboratory operating 10 branches and 960 sample collection centers across India and processing 5,000+ samples daily. It offers direct-to-consumer and physician-ordered tests including NIPT, paternity, whole exome sequencing, hereditary cancer, and HIV panels on an Illumina NovaSeq platform.
- Company typePrivate
- Founded2007
- HeadquartersHyderabad, India
- Headcount11–50
- GTM typeB2C
- OfferingServices
What DNA Labs India does
DNA Labs India is a private Indian genetic and specialty diagnostic testing laboratory headquartered in Hyderabad, Telangana, operating a national network of 10 branches and 960 sample collection centers that together process more than 5,000 samples per day. The company markets itself as "India's No.1 Genetic DNA Test Lab" and offers a broad test portfolio spanning relationship/paternity testing, non-invasive prenatal screening (NIPT), whole exome and clinical exome sequencing, hereditary cancer panels (BRCA1/2 and a 190-gene panel), oncology liquid biopsy, ancestry, methylation/epigenetic age, HLA typing, rabies PCR, and a tiered HIV testing menu (including a ₹200 confidential rapid test and RNA PCR early-detection assays). Underlying technology is an Illumina NovaSeq NGS platform with stated avoidance of Chinese reagents, complemented by PCR (qualitative and quantitative), High Performance Liquid Chromatography, and ELISA workflows, plus a "Tested Twice" verification protocol for higher accuracy. The lab claims ISO certification and NABL accreditation, and its chain-of-custody reports are accepted by foreign embassies (e.g., US Consulate) for immigration cases.
The business model is primarily direct-to-consumer transactional: customers book and pay online at dnalabsindia.com, with complimentary home sample collection for all online orders. Pricing is publicly listed in INR with aggressive discounts (typically 20-50% off "original" prices) and ranges from ₹200 for a confidential HIV rapid test to ₹33,000 for a 117-gene liquid biopsy panel. Go-to-market is hybrid, combining an e-commerce storefront, inside sales via city-specific phone lines, channel partnerships with third-party diagnostic clinics (Thyrocare, Varadaan, Phlebee, Health Monitors, Navi Mumbai Diagnostic Centre) that host collection services, and a high-volume content/SEO engine publishing 70+ blog pages per month plus dedicated city landing pages for Tier 1, 2, and 3 Indian markets. Customer segments are individual consumers and families, referring physicians across multiple specialties, and (less visibly) hospitals, pathology labs, and pharmaceutical companies. There is no public revenue, funding, or ownership disclosure, and AI/ML capabilities are not referenced in any source material.
DNA Labs India firmographics
Firmographics- Name
- DNA Labs India
- Legal name
- DNA Labs India
- Website
- https://dnalabsindia.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DNA Labs India is a Hyderabad-headquartered private genetic testing laboratory operating 10 branches and 960 sample collection centers across India and processing 5,000+ samples daily. It offers direct-to-consumer and physician-ordered tests including NIPT, paternity, whole exome sequencing, hereditary cancer, and HIV panels on an Illumina NovaSeq platform.
- Ownership category
- akta.pro rank
DNA Labs India industry classification
Industry- Product category
- Genetic and Molecular Diagnostic Testing Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industries
- Genetic & Prenatal Testing Laboratories (HLAFAMAH), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where DNA Labs India is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices11 records
Markets served
DNA Labs India business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Genetic and Diagnostic Test Sales: Core revenue is generated from direct one-time payments by customers for individual genetic and diagnostic tests (e.g., Paternity DNA Test ₹13,000, NIPT ₹10,000, WES ₹24,000, BRCA1/2 ₹14,000, Clinical Exome ₹20,000). Tests are purchased via the e-commerce storefront on dnalabsindia.com.
- Home Sample Collection Service Fees (bundled): Home sample collection is provided free of charge on all online bookings, serving as a customer acquisition lever rather than a standalone revenue stream; value is bundled into test pricing.
- B2B / Healthcare Professional Services: DNA Labs India explicitly states its services are advantageous to pathology labs, hospitals, patients, and pharmaceutical companies, indicating B2B revenue from institutional and channel customers alongside direct-to-consumer sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Paternity DNA Test - ₹13,000 (was ₹20,000) |
| Unit Pricing | Pay-as-you-go | NIPT (Non-Invasive Prenatal Test) - ₹10,000 (was ₹18,000) |
| Unit Pricing | Pay-as-you-go | DNA Genetic Methylation Test (DNA AGE) - ₹15,000 (was ₹30,000) |
| Unit Pricing | Pay-as-you-go | Whole Exome Sequencing (WES) + RAW DATA - ₹24,000 (was ₹35,000) |
| Unit Pricing | Pay-as-you-go | Breast Cancer BRCA1/BRCA2 Gene Test - ₹14,000 (was ₹28,000) |
| Unit Pricing | Pay-as-you-go | Clinical Exome NGS Test - ₹20,000 (was ₹28,000) |
| Unit Pricing | Pay-as-you-go | Comprehensive Hereditary Cancer Panel (190 Genes) - ₹25,000 (was ₹32,500) |
| Unit Pricing | Pay-as-you-go | HLA Typing Test - ₹8,000 |
| Unit Pricing | Pay-as-you-go | Hospital Baby Exchange Maternity DNA Test - ₹13,000 |
| Unit Pricing | Pay-as-you-go | RABIES Detection RNA Qualitative PCR Test - ₹6,000 |
| Unit Pricing | Pay-as-you-go | Liquid Biopsy 117 Gene Panel - ₹33,000 |
| Unit Pricing | Pay-as-you-go | Home DNA Test Kit - ₹1,000 |
| Unit Pricing | Pay-as-you-go | Catecholamines Plasma Test - ₹10,500 (was ₹15,000) |
| Unit Pricing | Pay-as-you-go | HIV Rapid / Blood Test - ₹200 |
| Unit Pricing | Pay-as-you-go | HIV DNA Test - ₹4,000 to ₹10,000 |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
DNA Labs India product offering
Product offeringCore offering
DNA Labs India is a Hyderabad-based genetic and molecular diagnostic laboratory that sells a portfolio of DNA and genetic tests directly to Indian consumers and institutional healthcare customers. Its tests span non-invasive prenatal testing (NIPT), paternity and maternity DNA tests, whole exome sequencing, clinical exome NGS, hereditary cancer panels (BRCA1/2 and a 190-gene OncoPro panel), ancestry and DNA methylation tests, HLA typing, rabies PCR, and a full HIV testing portfolio, all run on an Illumina NovaSeq NGS platform with a 'Tested Twice' verification workflow. Orders are taken through dnalabsindia.com, 10 owned branches, 960 sample collection centers, and free phlebotomist-led home sample collection across 1,000+ Indian cities.
Product overview
DNA Labs India is a genetic DNA testing laboratory offering a portfolio of discrete test products rather than a single unified SaaS platform. The portfolio centers on reproductive health screening (NIPT), relationship/paternity testing (Paternity and Maternity DNA Tests), comprehensive genomic sequencing (Whole Exome Sequencing and Clinical Exome NGS), hereditary cancer risk assessment (BRCA1/BRCA2 and the OncoPro Hereditary Cancer Panel), ancestry and epigenetic age testing (Family Tree Ancestry and DNA Methylation), infectious disease testing (RABIES RNA PCR, HIV RNA PCR), and niche genetic panels (HLA Typing, SNAI2, ADA, Epilepsy). Services are tied together by a centralized booking, sample-collection logistics network (10 branches and 960 sample collection centers across India with free home collection for online bookings), and an NGS testing platform that runs on Illumina NovaSeq instrumentation.
Differentiator
Problem solved
Functional benefit
Products and services
- NIPT NIFTY Non-Invasive Prenatal Test Non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in the fetus via a maternal blood sample, including Down syndrome risk assessment, for expectant parents. Listed at INR 10,000 on the homepage.
- Paternity DNA Test DNA paternity test confirming biological father-child relationship, suitable for personal, legal, and embassy/immigration use. Listed at INR 13,000 on the homepage.
- Hospital Baby Exchange Maternity DNA Test Maternity DNA test verifying the biological mother-child relationship, typically used to resolve suspected hospital baby-exchange situations. Listed at INR 13,000 across location pages.
- Whole Exome Sequencing (WES) Test + RAW DATA Next-generation sequencing test that sequences the protein-coding regions of the genome to aid diagnosis of rare genetic disorders, with raw sequencing data returned to the customer. Listed at INR 24,000.
- Clinical Exome NGS Test Targeted next-generation sequencing of clinically relevant genes to support diagnosis of inherited disorders. Listed at INR 20,000.
- OncoPro Hereditary Cancer Risk Panel (190 Genes) Test Comprehensive hereditary cancer risk panel covering 190 genes using NGS to assess inherited cancer predisposition. Listed at INR 25,000.
- Breast Cancer BRCA1 BRCA2 Gene Test NGS-based genetic test screening for mutations in the BRCA1 and BRCA2 genes to assess risk of hereditary breast and ovarian cancer. Listed at INR 15,000 on the homepage, INR 14,000 discounted.
- Family Tree Ancestry DNA Test Genealogy / ethnic ancestry DNA test that traces family lineage and ethnic origins. Listed at INR 15,000.
- DNA Genetic Methylation Test (MGMT Methylation Assay / DNA AGE Test) Methylation assay used both as an epigenetic age (DNA age) biomarker and as an MGMT promoter methylation test relevant to certain cancers. Listed at INR 15,000.
- HLA Typing Test Single-person HLA typing test used to determine donor-recipient compatibility for organ and stem cell transplantation. Listed at INR 8,000.
- RABIES Detection RNA Qualitative PCR Test Qualitative RNA PCR test for early detection of rabies virus, supporting timely post-exposure decision-making. Listed at INR 6,000.
- Liquid Biopsy 117 Gene Panel Non-invasive blood-based liquid biopsy that detects and monitors diseases such as cancer by analyzing circulating tumor DNA across 117 genes. Listed at INR 33,000.
- Liquid Biopsy Cancer Therapy Chemo Sensitivity Test Liquid biopsy-based test that helps identify the most effective chemotherapy options for cancer patients based on tumor genetic profile. Listed at INR 20,000.
- Home DNA Test Kit (Swab Self-Collection) Self-collection buccal/swab DNA test kit that allows customers to collect a DNA sample at home and ship it to the lab for paternity, maternity, ancestry and similar tests. Listed at INR 1,000.
- Catecholamines Plasma Test Plasma catecholamines test (epinephrine, norepinephrine, dopamine) used to diagnose pheochromocytoma, paraganglioma and related neuroendocrine tumors; performed by High Performance Liquid Chromatography. Listed at INR 10,500.
- HIV RNA PCR Qualitative Test Qualitative HIV RNA PCR test that detects HIV genetic material as early as 10-14 days post-exposure, returning a 'Detected' or 'Not Detected' result.
- HIV RNA Quantitative Real-Time PCR (Viral Load) Test Quantitative HIV RNA PCR test that measures viral load to monitor ART treatment effectiveness and disease progression.
- HIV 1 & 2 Antibodies Screening Test Antibody screening test for HIV-1 and HIV-2 infections, performed on blood or oral fluid.
- HIV 4th Generation (Antigen/Antibody Combo) Rapid Blood Test Fourth-generation HIV test that simultaneously detects HIV-1/2 antibodies and p24 antigen, enabling detection 2-4 weeks after exposure.
- Rapid HIV Test (Point-of-Care) Point-of-care rapid HIV test offered for INR 200, with rapid tests at 4 weeks post-exposure identifying approximately 95% of HIV infections.
- Nx Gen Sequencing: Comprehensive Epilepsy Test Next-generation sequencing panel for comprehensive epilepsy genetic testing from whole blood (EDTA). Listed at INR 23,400.
- SNAI2 Gene Piebaldism NGS Genetic Test NGS-based genetic test for SNAI2 gene mutations associated with piebaldism.
- ADA Gene Severe Combined Immunodeficiency (ADA-SCID) NGS Genetic Test NGS-based genetic test for ADA gene mutations causing severe combined immunodeficiency due to ADA deficiency.
- Free Home Sample Collection Service Complimentary home sample collection service provided across India for all online test bookings, supported by a network of 10 branches and 960 sample collection centers processing over 5,000 samples daily.
Quantifiable outcome
- 10 branches + 960 sample collection centers across India
- +6 more outcomes
Companies that use DNA Labs India
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
DNA Labs India technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
DNA Labs India partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Thyrocare CharniroadcoreThyrocare Charniroad (114/1, Trinity CHS Ltd., Dr. Cawasji Hormusji Street, Dhobi Talao, Marine Lines East, Mumbai 400002) hosts DNA Labs India's Mumbai sample collection center. DNA Labs India describes its relationship to Thyrocare as a customer-facing collection point within a hospital-grade facility.
- Phlebee Healthcare Network Pvt. LtdcorePhlebee Healthcare Network (Spencer Plaza, 715-A, 7th Floor, Suite 293, Anna Salai, Chennai 600002) hosts DNA Labs India's Chennai sample collection center at the Phlebee facility.
- Varadaan Diagnostic CentrecoreVaradaan Diagnostic Centre (3rd Floor, Varadaan Building, Eduljee Road, Tembhi Naka, Thane, Maharashtra 400601) hosts DNA Labs India's Thane branch sample collection facility.
- Navi Mumbai Diagnostic CentrecoreNavi Mumbai Diagnostic Centre (2nd Floor, Building No K 2/4, Market Main Road, Vashi Sector 15, Navi Mumbai 400703) hosts DNA Labs India's Navi Mumbai sample collection facility.
- HEALTH MONITORScoreHEALTH MONITORS (No 123, Ground Floor, 18th Main Road, Hal 2nd Stage, Indira Nagar, Bangalore 560008) hosts DNA Labs India's Bangalore branch and sample collection services.
- Illumina (NovaSeq platform vendor)coreDNA Labs India's NGS test platform is Illumina NovaSeq. This is a technology supply relationship for sequencing instruments/reagents underpinning its WES, Clinical Exome, and hereditary cancer panel offerings.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
DNA Labs India competitors and assessment
Company assessmentBroad incumbents
- Apollo Diagnostics: Diagnostics arm of Apollo Hospitals offering preventive, routine, and specialty tests including genetics; overlaps with DNA Labs India's consumer and clinician-focused test menu across Indian metros and Tier 2 cities.
- Metropolis Healthcare: National Indian diagnostics chain with extensive specialty and molecular testing; offers comparable services to DNA Labs India's hospital/clinician segment and competes for B2B and consumer volumes across Indian metros.
- Dr. Lal PathLabs: Largest organized diagnostic chain in India with pan-India collection centers, NABL accreditation, and a growing molecular/genetics menu; competes with DNA Labs India for hospital referrals and consumer preventive testing across the same geography.
- SRL Diagnostics: Large Indian diagnostics network with a molecular and specialty testing portfolio; competes for hospital and clinician sample referrals and shares DNA Labs India's pan-India coverage ambition.
- Neuberg Diagnostics: Pan-India diagnostic chain with a strong molecular and genomics vertical; competes with DNA Labs India for clinician referrals and consumer specialty testing across multiple Indian states.
Direct peers
- Strand Life Sciences: India-based genomics and clinical diagnostics company with NGS-based hereditary and oncology panels and bioinformatics capabilities; competes with DNA Labs India in clinical genomics, especially oncology and rare disease panels.
- Mapmygenome: Indian direct-to-consumer and clinical genomics company offering preventive health, ancestry, NIPT, and hereditary cancer genetic tests; competes for the same Indian consumer health and clinician referral customers.
- MedGenome: India- and US-headquartered genomics company focused on NGS-based clinical genetic testing, hereditary cancer panels, and prenatal screening; directly competes with DNA Labs India's WES, Clinical Exome, BRCA, and NIPT offerings.
- Thyrocare Technologies: Thyrocare operates a national Indian preventive and specialty diagnostics network and explicitly hosts a DNA Labs India collection center in Mumbai; both compete for the same Indian consumer and clinician testing wallet with overlapping assay menus and home-collection logistics.
Regional players
- 23andMe: US-based direct-to-consumer genetic testing leader in ancestry and health-risk reports; comparable product category (consumer ancestry and health-risk DNA testing) but does not currently serve the Indian market with the same clinical and legal-testing depth.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DNA Labs India social profiles
Digital presenceDNA Labs India compliance and trust
Trust signalCompliance2 records
DNA Labs India financial estimates
Financial estimateRevenue estimate
Valuation estimate
DNA Labs India leadership team
Management profileNumber of profiles
Profiles2 records
DNA Labs India subsidiaries and ownership
Company hierarchySubsidiaries18 records
DNA Labs India funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DNA Labs India M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DNA Labs India
What does DNA Labs India do?
DNA Labs India is a Hyderabad-based genetic and molecular diagnostic laboratory that sells a portfolio of DNA and genetic tests directly to Indian consumers and institutional healthcare customers. Its tests span non-invasive prenatal testing (NIPT), paternity and maternity DNA tests, whole exome sequencing, clinical exome NGS, hereditary cancer panels (BRCA1/2 and a 190-gene OncoPro panel), ancestry and DNA methylation tests, HLA typing, rabies PCR, and a full HIV testing portfolio, all run on an Illumina NovaSeq NGS platform with a 'Tested Twice' verification workflow. Orders are taken through dnalabsindia.com, 10 owned branches, 960 sample collection centers, and free phlebotomist-led home sample collection across 1,000+ Indian cities.
Is DNA Labs India a public or private company?
DNA Labs India is a private company. It is classified as unknown and is currently operating.
When was DNA Labs India founded?
DNA Labs India was founded in 2007. It employs 11 to 50 people.
Where is DNA Labs India based?
DNA Labs India is headquartered in Hyderabad, India, in the Asia region.
How does DNA Labs India make money?
Three revenue lines are on record. Genetic and Diagnostic Test Sales are the primary driver. The others are home Sample Collection Service Fees (bundled) and B2B / Healthcare Professional Services.
Who are DNA Labs India's main competitors?
Broad incumbents on record are Apollo Diagnostics, Metropolis Healthcare, Dr. Lal PathLabs, SRL Diagnostics and Neuberg Diagnostics. Direct peers are Strand Life Sciences, Mapmygenome, MedGenome and Thyrocare Technologies. 23andMe is listed as a regional player.
Does DNA Labs India have an API?
No public API is recorded for DNA Labs India.
What industry is DNA Labs India in?
DNA Labs India's product category is Genetic and Molecular Diagnostic Testing Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.